LEU vs SOLS
LEU: Domestic uranium enrichment provider supplying low-enriched uranium (LEU) and high-assay low-enriched uranium (HALEU) to U.S. nuclear power plants and the Department of Energy. SOLS: A specialized chemical and materials manufacturer with a focus on products for the nuclear energy industry, recently operating as an independent public company.
Side-by-side fundamentals
| Metric | LEU | SOLS | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $175.98 | $60.17 | |
| Market cap as of 2026-08-03 | $3.5B | $9.6B | |
| P/E as of 2026-08-03 | 57.44 | 45.69 | SOLS lower |
| Net margin as of 2026-08-03 | +13.4% | +5.1% | LEU higher |
| Gross margin as of 2026-08-03 | +25.7% | +30.6% | SOLS higher |
| Operating margin as of 2026-08-03 | +6.7% | +13.9% | SOLS higher |
| ROE as of 2026-08-03 | +10.7% | +10.9% | SOLS higher |
| ROA as of 2026-08-03 | +2.9% | +3.7% | SOLS higher |
| Debt / equity as of 2026-08-03 | 1.52 | 1.53 | LEU lower |
| Revenue growth (YoY) as of 2026-08-03 | -4.0% | -28.2% | LEU higher |
| Revenue CAGR (3y) SEC XBRL | +15.2% | +3.2% | LEU higher |
| Dividend yield as of 2026-08-03 | n/a | +0.5% | |
| Beta as of 2026-08-03 | 1.37 | 0.35 | |
| 1-year return as of 2026-07-27 close | -27.0% | n/a |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.